Content:
- Company Overview of Vijaya Diagnostic Centre Ltd
- Company Overview of Krsnaa Diagnostics Ltd
- The Stock Performance of Vijaya Diagnostic Centre Limited
- The Stock Performance of Krsnaa Diagnostics Limited
- Fundamental Analysis of Vijaya Diagnostic Centre Ltd
- Fundamental Analysis of Krsnaa Diagnostics
- Financial Comparison of Vijaya Diagnostic Centre and Krsnaa Diagnostics
- Dividend of Vijaya Diagnostic Centre and Krsnaa Diagnostics
- Advantages and Disadvantages of Investing in Vijaya Diagnostic Centre Limited
- Advantages and Disadvantages of Investing in Krsnaa Diagnostics
- How to Invest in Krsnaa Diagnostics and Vijaya Diagnostic Centre Stocks?
- Vijaya Diagnostic Centre vs. Krsnaa Diagnostics Limited- Conclusion
- Vijaya Diagnostic Centre vs. Krsnaa Diagnostics – FAQ
Company Overview of Vijaya Diagnostic Centre Ltd
Vijaya Diagnostic Centre Limited, a company based in India, provides a wide range of diagnostic services, including pathological investigations, basic and advanced radiology, nuclear medicine, and other healthcare services.
The company operates primarily in the Diagnostic Services segment and offers a diverse test menu that includes pathology tests from basic biochemistry to high-end molecular diagnostics, as well as radiology tests ranging from standard X-rays to advanced imaging such as CT scans, MRI scans, SPECT, and PET CT scans.
Company Overview of Krsnaa Diagnostics Ltd
Krsnaa Diagnostics Limited, based in India, provides diagnostic services in radiology and pathology throughout the country. The company specializes in offering services such as X-rays, CT scans, MRIs, mammography, tele-reporting, as well as various blood and urine tests. Its advanced technology assists healthcare professionals in diagnosing and treating medical conditions through internal imaging of the human body.
The company’s laboratory services range from routine tests to specialized investigations and health packages like Ayaksham-Total, Bone Health-Advance, Fever Profile-Basic, Hypertension Profile are also available. Krsnaa Diagnostics serves a wide range of clients including public and private hospitals, medical colleges, and community health centers.
The Stock Performance of Vijaya Diagnostic Centre Limited
The table below displays the month-by-month stock performance of Vijaya Diagnostic Centre Ltd for the past year.
Month | Return (%) |
Mar-2024 | -0.53 |
Apr-2024 | 9.86 |
May-2024 | 16.4 |
Jun-2024 | -9.6 |
Jul-2024 | 5.57 |
Aug-2024 | 16.11 |
Sep-2024 | 3.49 |
Oct-2024 | 4.3 |
Nov-2024 | 17.25 |
Dec-2024 | -9.41 |
Jan-2025 | -1.45 |
Feb-2025 | -12.28 |
The Stock Performance of Krsnaa Diagnostics Limited
The table below displays the month-by-month stock performance of Krsnaa Diagnostics Ltd for the past year.
Month | Return (%) |
Mar-2024 | -6.18 |
Apr-2024 | -6.39 |
May-2024 | -2.67 |
Jun-2024 | 5.16 |
Jul-2024 | 11.48 |
Aug-2024 | 6.38 |
Sep-2024 | 15.75 |
Oct-2024 | 10.81 |
Nov-2024 | 4.82 |
Dec-2024 | -12.48 |
Jan-2025 | -4.88 |
Feb-2025 | -16.19 |
Fundamental Analysis of Vijaya Diagnostic Centre Ltd
Vijaya Diagnostic Centre Ltd is a prominent healthcare provider based in India, specializing in diagnostic services. Established in 1981, the company has built a strong reputation for its high-quality diagnostic testing, including laboratory tests and imaging services. With a commitment to accuracy and patient care, Vijaya Diagnostic Centre serves a vast clientele across multiple locations, making it a trusted name in the healthcare sector.
The stock is currently priced at ₹1,013.55, with a market capitalization of ₹10,311.35 crore. It has delivered a strong 1-year return of 66.16% and a 6-month return of 10.40%. It remains 25.80% below its 52-week high, with a 5-year average net profit margin of 20.25%, indicating strong profitability. The dividend yield is 0.10%, reflecting modest returns for investors.
- Close Price ( ₹ ): 1013.55
- Market Cap ( Cr ): 10311.35
- Dividend Yield %: 0.10
- 1Y Return %: 66.16
- 6M Return %: 10.40
- 1M Return %: 2.72
- % Away From 52W High: 25.80
- 5Y Avg Net Profit Margin %: 20.25
Fundamental Analysis of Krsnaa Diagnostics
Krsnaa Diagnostics is a prominent healthcare organization specializing in providing diagnostic services across India. Established with the aim of delivering high-quality medical care, the company focuses on enhancing patient outcomes through advanced technology and comprehensive healthcare solutions. Their services range from radiology to laboratory testing, catering to a diverse clientele.
The stock is currently priced at ₹706.80, with a market capitalization of ₹2,354.09 crore. Over the past year, it has delivered a 26.02% return, though it has seen a 12.16% decline in the last six months. It remains 47.71% below its 52-week high, reflecting potential for recovery. The dividend yield is 0.34%, providing modest returns to investors.
- Close Price ( ₹ ): 706.80
- Market Cap ( Cr ): 2354.09
- Dividend Yield %: 0.34
- 1Y Return %: 26.02
- 6M Return %: -12.16
- 1M Return %: -11.87
- % Away From 52W High: 47.71
Financial Comparison of Vijaya Diagnostic Centre and Krsnaa Diagnostics
The table below shows a financial comparison of Vijaya Diagnostic Centre Ltd and Krsnaa Diagnostics Ltd.
Stock | VIJAYA | KRSNAA | ||||
Financial type | FY 2023 | FY 2024 | TTM | FY 2023 | FY 2024 | TTM |
Total Revenue (₹ Cr) | 473.37 | 568.63 | 679.38 | 506.5 | 636.43 | 722.85 |
EBITDA (₹ Cr) | 196.18 | 239.67 | 283.48 | 141.68 | 161.04 | 206.33 |
PBIT (₹ Cr) | 134.46 | 182.67 | 215.41 | 87.9 | 86.49 | 121.84 |
PBT (₹ Cr) | 113.51 | 158.68 | 189.66 | 80.2 | 70.0 | 96.68 |
Net Income (₹ Cr) | 84.63 | 118.83 | 141.88 | 62.11 | 56.83 | 75.63 |
EPS (₹) | 8.3 | 11.63 | 13.86 | 19.78 | 17.85 | 23.42 |
DPS (₹) | 1.0 | 1.0 | 1.00 | 2.75 | 2.5 | 2.50 |
Payout ratio (%) | 0.12 | 0.09 | 0.07 | 0.14 | 0.14 | 0.11 |
Points to be noted:
- (TTM) Trailing 12 Months – Trailing 12 months (TTM) is used to describe the past 12 consecutive months of a company’s performance data when reporting financial figures.
- EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization): Measures a company’s profitability before accounting for financial and non-cash expenses.
- PBIT (Profit Before Interest and Tax): Reflects operating profit by excluding interest and taxes from total revenue.
- PBT (Profit Before Tax): Indicates profit after deducting operating costs and interest but before taxes.
- Net Income: Represents the company’s total profit after all expenses, including taxes and interest, are deducted.
- EPS (Earnings Per Share): Shows the portion of a company’s profit allocated to each outstanding share of stock.
- DPS (Dividend Per Share): Reflects the total dividend paid out per share over a specific period.
- Payout Ratio: Measures the proportion of earnings distributed as dividends to shareholders.
Dividend of Vijaya Diagnostic Centre and Krsnaa Diagnostics
Vijaya Diagnostic Centre and Krsnaa Diagnostics both offer consistent final dividends, with Krsnaa providing slightly higher payouts. Both companies demonstrate strong financial commitment to their shareholders through regular dividend announcements. Check the table for complete details.
Vijaya Diagnostic Centre | Krsnaa Diagnostics | ||||||
Announcement Date | Ex-Dividend Date | Dividend Type | Dividend (Rs) | Announcement Date | Ex-Dividend Date | Dividend Type | Dividend (Rs) |
8 May, 2024 | 30 August, 2024 | Final | 1 | 21 May, 2024 | 13 September, 2024 | Final | 2.5 |
29 May, 2023 | 13 September, 2023 | Final | 1 | 29 May, 2023 | 15 September, 2023 | Final | 2.75 |
26 May, 2022 | 20 September, 2022 | Final | 1 | 30 May, 2022 | 15 September, 2022 | Final | 2.5 |
Advantages and Disadvantages of Investing in Vijaya Diagnostic Centre Limited
Vijaya Diagnostic Centre Ltd
The primary advantage of Vijaya Diagnostic Centre Ltd lies in its strong presence in the diagnostic services industry. Known for its high-quality services and wide network of centers, the company benefits from a growing healthcare sector, which drives consistent demand for diagnostic testing and imaging services.
- Established Brand Reputation
Vijaya Diagnostic Centre is recognized for its reliable and accurate diagnostic services, building trust among patients. Its strong brand reputation helps maintain customer loyalty and differentiates it from competitors in a fragmented market. - Wide Network of Centres
With a growing network of diagnostic centers across India, Vijaya has made healthcare more accessible, particularly in urban and semi-urban areas. This widespread presence allows the company to capture a large customer base. - Strong Focus on Technology
The company invests in cutting-edge diagnostic technology and equipment, improving service accuracy and efficiency. By staying at the forefront of technological advancements, Vijaya Diagnostics maintains high standards, attracting more patients and improving its market position. - Experienced Management Team
Vijaya’s experienced leadership team ensures strategic decision-making, operational efficiency, and sustained growth. Their expertise in the healthcare sector guides the company through regulatory challenges, market expansion, and innovation in diagnostic services. - Rising Healthcare Demand
As the healthcare industry in India continues to grow, the demand for diagnostic services is on the rise. Vijaya Diagnostics is well-positioned to capitalize on this trend, especially with increasing awareness of health and preventive care.
The main disadvantage of Vijaya Diagnostic Centre Ltd is its heavy reliance on the highly competitive and fragmented diagnostic services market. With increasing competition from both organized and unorganized players, maintaining market share and profitability can be challenging in the long run.
- Intense Competition
Vijaya Diagnostic faces stiff competition from well-established players like Dr. Lal PathLabs and Metropolis Healthcare, as well as regional diagnostic centers. The growing number of private and unorganized competitors makes it difficult to maintain a dominant market position. - Regulatory and Compliance Risks
The healthcare sector is highly regulated, with strict rules for diagnostic testing. Any changes in regulations or failure to comply with quality standards could lead to operational disruptions, legal challenges, or reputational damage, impacting the company’s growth. - Dependence on Urban Markets
Vijaya Diagnostic Centre’s revenue largely depends on urban and semi-urban markets. Expanding into rural areas requires significant investment in infrastructure, making it challenging to scale operations while maintaining profitability and service quality in less lucrative regions. - Technological Upgradation Costs
As a diagnostics company, Vijaya continuously needs to invest in cutting-edge technology to stay competitive. While technological advancement improves service quality, the high costs of upgrading equipment and training staff can impact short-term profitability. - Vulnerability to Economic Downturns
As a healthcare service provider, Vijaya Diagnostic is somewhat insulated from economic downturns. However, prolonged economic slowdowns can affect discretionary spending on health checkups and diagnostics, leading to a decline in footfall and revenue.
Advantages and Disadvantages of Investing in Krsnaa Diagnostics
Krsnaa Diagnostics Ltd
The primary advantage of Krsnaa Diagnostics Ltd is its strong position in the diagnostic sector, with a focus on providing affordable and accessible healthcare services.
- Wide Network of Centers
Krsnaa Diagnostics operates a large network of diagnostic centers across India, improving healthcare access in both urban and rural areas. This widespread presence helps capture a broad customer base, providing consistent revenue growth opportunities. - Focus on Affordable Healthcare
Krsnaa differentiates itself by offering high-quality diagnostic services at competitive prices. This focus on affordability attracts a large segment of cost-conscious customers, enabling the company to cater to a wider demographic, especially in price-sensitive regions. - Strong Technological Integration
The company invests heavily in advanced diagnostic technologies, which enhances the accuracy and speed of results. This technological edge not only improves service delivery but also builds consumer trust, enhancing its competitive position in the diagnostics market. - Strategic Partnerships and Collaborations
Krsnaa Diagnostics has partnered with both public and private sector hospitals, enabling it to expand its reach and client base. These collaborations help strengthen its market position and ensure a steady flow of diagnostic tests from a diverse clientele. - Growing Healthcare Market
The healthcare and diagnostics sector in India is witnessing rapid growth, driven by increasing health awareness and government initiatives. Krsnaa is well-positioned to benefit from this trend, tapping into a larger market while maintaining service quality and reliability.
The main disadvantage of Krsnaa Diagnostics Ltd is its dependence on the highly competitive and price-sensitive diagnostic services market. With numerous established and emerging players, maintaining market share and profitability can be difficult, especially with the constant need for technological investments and regulatory compliance.
- Intense Market Competition
Krsnaa faces strong competition from both established diagnostic chains like Dr. Lal PathLabs and regional players. With the growing number of private labs and unorganized centers, standing out in terms of quality and pricing becomes challenging. - Regulatory Challenges
Operating in the healthcare sector, Krsnaa Diagnostics is subject to strict government regulations concerning test accuracy, safety standards, and certifications. Any regulatory changes or non-compliance could result in financial penalties or operational disruptions, affecting the company’s market performance. - Dependence on Urban and Semi-Urban Markets
A significant portion of Krsnaa’s revenue comes from urban and semi-urban markets. While expansion into rural regions offers growth potential, it also demands substantial investments in infrastructure and logistics, which may strain the company’s resources and profitability. - Costly Technological Upgrades
Continuous investments in advanced diagnostic technologies are necessary to maintain a competitive edge. While these upgrades improve service quality, the associated costs impact short-term profitability, creating challenges for cost management in an increasingly competitive market. - Vulnerability to Economic Cycles
Economic downturns can reduce discretionary spending on health check-ups, especially in times of financial uncertainty. While healthcare is essential, prolonged recessions or changes in consumer behavior could impact the demand for diagnostic services, affecting Krsnaa’s growth prospects.
How to Invest in Krsnaa Diagnostics and Vijaya Diagnostic Centre Stocks?
Suppose you’re interested in investing in Krsnaa Diagnostics and Vijaya Diagnostic Centre Stocks. In that case, you can do so effortlessly through Alice Blue, which offers zero brokerage on equity delivery trades, allowing you to purchase stocks without any additional charges.
Step 1: Open a Demat & Trading Account
- Visit the Alice Blue website.
- Click on “Open Demat Account” and complete the registration process.
- Upload your PAN, Aadhaar, and bank details for verification.
Step 2: Fund Your Trading Account
- Log in to Alice Blue and navigate to the Funds section.
- Deposit money using UPI, Net Banking, or NEFT/RTGS for seamless transactions.
Step 3: Search & Analyze Krsnaa Diagnostics and Vijaya Diagnostic Centre Stocks
- Use the search bar to find Krsnaa Diagnostics and Vijaya Diagnostic Centre Stocks.
- Review the stock’s market price, charts, and company insights before making a decision.
Step 4: Place Your Buy Order
- Click “Buy” and select either a Market Order (instant purchase) or a Limit Order (buy at a specified price).
- Enter the quantity and confirm your order to complete the purchase.
Vijaya Diagnostic Centre vs. Krsnaa Diagnostics Limited- Conclusion
Vijaya Diagnostic Centre Ltd has a strong presence in the diagnostic sector with a reputation for quality and a growing network across India. However, its reliance on competitive urban markets and regulatory pressures presents challenges. Expanding into rural areas and improving technological investments are key for sustained growth.
Krsnaa Diagnostics Ltd benefits from its focus on affordable healthcare and an expanding network across India. Its strategic partnerships and technological advancements offer significant growth opportunities. However, competition and regulatory complexities in the diagnostic industry pose challenges that Krsnaa must address to maintain its competitive edge.
Vijaya Diagnostic Centre vs. Krsnaa Diagnostics – FAQ
Vijaya Diagnostic Centre Ltd is a prominent healthcare provider in India, specializing in diagnostic services. It offers a wide range of medical tests and solutions, including laboratory and radiology services, aimed at supporting patient care and enhancing diagnostic accuracy for various health conditions.
Krsnaa Diagnostics Ltd is a prominent healthcare company based in India, specializing in diagnostic services. They offer a range of medical testing and imaging solutions, utilizing advanced technology to deliver accurate results. The company aims to enhance patient care through accessible and efficient diagnostic services.
Healthcare stocks belong to companies involved in the medical, pharmaceutical, biotechnology, and healthcare services sectors. These stocks represent companies that provide products and services related to health and wellness, such as hospitals, medical equipment, drugs, and diagnostics.
Sura Suprita Reddy serves as the Managing Director and Chief Executive Officer (CEO) of Vijaya Diagnostic Centre Ltd. She has been with the company since 2003, overseeing strategy, clinical excellence, operations, and expansion. She was appointed as CEO effective July 1, 2023.
The main competitors for Vijaya Diagnostic Centre and Krsnaa Diagnostics include established players like Dr. Lal PathLabs, Metropolis Healthcare, and Thyrocare Technologies. These companies dominate the diagnostic services market with extensive networks, advanced technology, and strong brand recognition, making competition intense in the healthcare sector.
As of March 2025, Vijaya Diagnostic Centre Ltd has a market capitalization of approximately ₹10,577 crore. In comparison, Krsnaa Diagnostics Ltd has a market capitalization of around ₹2,293 crore. Therefore, Vijaya Diagnostic Centre’s market cap is significantly higher than that of Krsnaa Diagnostics.
Vijaya Diagnostic Centre is focusing on expanding its network of diagnostic centers across India, especially in underserved regions. The company is also investing in advanced technology, automation, and digital health services to improve efficiency and service quality. Expanding into telemedicine and increasing market share are key growth strategies.
Krsnaa Diagnostics Ltd is focusing on expanding its network of diagnostic centers across India, especially in tier 2 and tier 3 cities. The company is also investing in advanced technology for accurate and faster results, exploring international expansion, and enhancing its digital healthcare services to cater to growing demand.
Krsnaa Diagnostics offers better dividends compared to Vijaya Diagnostic Centre, with a higher payout in recent years. While Vijaya Diagnostics also provides dividends, Krsnaa has a more consistent and higher dividend yield, making it a more attractive option for dividend-seeking investors.
For long-term investors, Vijaya Diagnostic Centre is a better option due to its established market presence, larger scale, and consistent financial performance. While Krsnaa Diagnostics offers growth potential, especially with its expanding network, Vijaya Diagnostics provides more stability and a stronger foothold in the diagnostics market.
Vijaya Diagnostic Centre generates most of its revenue from diagnostic services, including pathology and radiology. Similarly, Krsnaa Diagnostics derives significant revenue from pathology services, with increasing contributions from radiology and telemedicine services. Both companies focus on expanding their presence in these high-demand healthcare sectors.
Vijaya Diagnostic Centre Ltd exhibits higher profitability, with a net profit margin of 21.82% in the latest fiscal year. In contrast, Krsnaa Diagnostics Ltd has a net profit margin of 10.85%. Therefore, Vijaya Diagnostic Centre is more profitable than Krsnaa Diagnostics.
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.